173 related articles for article (PubMed ID: 1736525)
1. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes.
Petit MA; Capel F; Dubanchet S; Mabit H
Virology; 1992 Mar; 187(1):211-22. PubMed ID: 1736525
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands.
Petit MA; Strick N; Dubanchet S; Capel F; Neurath AR
Mol Immunol; 1991; 28(4-5):517-21. PubMed ID: 1712075
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain.
Budkowska A; Bedossa P; Groh F; Louise A; Pillot J
J Virol; 1995 Feb; 69(2):840-8. PubMed ID: 7815551
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus.
Petit MA; Dubanchet S; Capel F
Mol Immunol; 1989 Jun; 26(6):531-7. PubMed ID: 2475766
[TBL] [Abstract][Full Text] [Related]
5. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface.
Pontisso P; Ruvoletto MG; Tiribelli C; Gerlich WH; Ruol A; Alberti A
J Gen Virol; 1992 Aug; 73 ( Pt 8)():2041-5. PubMed ID: 1645141
[TBL] [Abstract][Full Text] [Related]
6. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).
Petit MA; Dubanchet S; Capel F; Voet P; Dauguet C; Hauser P
Virology; 1991 Feb; 180(2):483-91. PubMed ID: 1703368
[TBL] [Abstract][Full Text] [Related]
7. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.
Xu X; Li GD; Kong YY; Yang HL; Zhang Z; Cao HT; Wang Y
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3673-7. PubMed ID: 7527840
[TBL] [Abstract][Full Text] [Related]
8. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
[TBL] [Abstract][Full Text] [Related]
9. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
10. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
11. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
Meier A; Mehrle S; Weiss TS; Mier W; Urban S
Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
[TBL] [Abstract][Full Text] [Related]
12. Detection of receptors for hepatitis B virus on cells of extrahepatic origin.
Neurath AR; Strick N; Sproul P; Ralph HE; Valinsky J
Virology; 1990 Jun; 176(2):448-57. PubMed ID: 2161145
[TBL] [Abstract][Full Text] [Related]
13. Primary cultured normal human hepatocytes for hepatitis B virus receptor studies.
Mabit H; Vons C; Dubanchet S; Capel F; Franco D; Petit MA
J Hepatol; 1996 Apr; 24(4):403-12. PubMed ID: 8738726
[TBL] [Abstract][Full Text] [Related]
14. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site.
Wi J; Jeong MS; Hong HJ
J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsonins.
Atkins GJ; Qiao M; Coombe DR; Gowans EJ; Ashman LK
Immunol Cell Biol; 1997 Jun; 75(3):259-66. PubMed ID: 9243291
[TBL] [Abstract][Full Text] [Related]
16. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers.
Treichel U; Meyer zum Büschenfelde KH; Stockert RJ; Poralla T; Gerken G
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3021-9. PubMed ID: 7964611
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity.
Duclos-Vallée JC; Capel F; Mabit H; Petit MA
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1665-70. PubMed ID: 9680129
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor.
Budkowska A; Quan C; Groh F; Bedossa P; Dubreuil P; Bouvet JP; Pillot J
J Virol; 1993 Jul; 67(7):4316-22. PubMed ID: 8510225
[TBL] [Abstract][Full Text] [Related]
20. N-terminal myristylation of HBV preS1 domain enhances receptor recognition.
De Falco S; Ruvo M; Verdoliva A; Scarallo A; Raimondo D; Raucci A; Fassina G
J Pept Res; 2001 May; 57(5):390-400. PubMed ID: 11350599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
